The role of bacterial muramyl dipeptide as a postbiotic has also been documented in reducing inflammation and promoting insulin signaling in the state of metabolic endotoxemia, glycemia, and obesity via a pathway that involves NOD2 (30). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.